bf/NASDAQ:LUCD_icon.jpeg

NASDAQ:LUCD

Lucid Diagnostics Inc.

  • Stock

USD

Last Close

1.07

06/11 21:56

Market Cap

44.21M

Beta: -

Volume Today

768.66K

Avg: 95.62K

PE Ratio

−0.03

PFCF: −2.29

    Description

    Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company. The company focuses on patients with gastroesophageal reflux disease, which is also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically highly lethal esophageal adenocarcinoma. Its lead products include ...Show More

    Earnings

    Earnings per Share (Estimate*)

    -0.4-0.20.20.42018-12-302021-03-312022-05-112023-11-132024-05-202025-06-20

    Revenue (Estimate*)

    200K400K600K800K1M1.20M1.40M2018-12-302021-03-312022-05-112023-11-132024-05-202025-06-20

    *Estimate based on analyst consensus